(Total Views: 71)
Posted On: 10/30/2024 10:44:38 AM
Post# of 89358

$GNLX Genelux doses first subject in Phase II trial of NSCLC treatment
https://finance.yahoo.com/news/genelux-doses-...30466.html
https://finance.yahoo.com/news/genelux-doses-...30466.html

